← All stories
Markets

Why Celadon (LSE:CEL) Is in Focus After It remained a current UK medical-cannabis listing under review

1 source ·1 article ·8h ago Leishen Energy Holding Co., Ltd.

Highlights Celadon Pharmaceuticals (LSE:CEL) remained a current UK medical-cannabis listing under review, adding a fresh verified development to the market record. The central analytical theme is regulated cultivation and commercial access,…

Covered by 1 outlet

All coverage · 1 article